免疫系统
自身免疫
生物
B细胞
免疫学
点头老鼠
点头
炎症
自身免疫性疾病
细胞生物学
调节性B细胞
信号转导
T细胞
疾病
1型糖尿病
分泌物
细胞因子
癌症研究
关节炎
免疫耐受
NFKB1型
细胞
糖尿病
糖酵解
白细胞介素10
代谢途径
电池类型
免疫
先天免疫系统
功能(生物学)
获得性免疫系统
作者
Holly Conway,Jessica K. Bernard,Rachel Ramos,Sama Zahran,Dianna Perez,Mugtaba Swar-Eldahab,Jon D. Piganelli,Carmella Evans-Molina,Jamie L. Felton
标识
DOI:10.1093/jimmun/vkaf330
摘要
Abstract Type 1 diabetes (T1D) results from immune-mediated destruction of pancreatic beta cells. B cells serve as critical antigen-presenting cells whose autoreactive specificities drive disease progression. Conversely, IL-10 producing regulatory B cells (Bregs) exert immunosuppressive functions and have been shown to protect against autoimmunity in mouse models of rheumatoid arthritis and multiple sclerosis, where microenvironmental cues promote their differentiation. In particular, signaling through hypoxia-inducible factor 1α (HIF-1α) induces glycolytic flux that supports Breg expansion. Defects in Breg development and function have been identified in both human T1D and the non-obese diabetic (NOD) mouse, but whether these impairments reflect intrinsic B-cell abnormalities or microenvironmental changes associated with hyperglycemia and inflammation remains unclear. Moreover, the mechanisms by which B cells suppress pathogenic T-cell responses likely vary across disease states. Here, we examine how B cell differentiation, metabolism, and HIF-1α signaling interact to shape immune regulation in autoimmune diabetes. We show that B cells undergo dynamic metabolic remodeling during disease progression. B cells from NOD mice are characterized by exaggerated glucose uptake and elevated IL-10 expression compared with non-autoimmune B6 B cells, despite reduced HIF-1α levels and attenuated induction of HIF-dependent glycolytic genes. These findings indicate that HIF-1α plays a diminished role in controlling IL-10 production in NOD B cells and that IL-10 alone is insufficient to maintain immune tolerance. Together, our results highlight how genetic and microenvironmental factors reprogram B cell metabolism and underscore the need to explore IL-10 independent pathways and B-cell extrinsic mechanisms when developing immunomodulatory therapies for T1D.
科研通智能强力驱动
Strongly Powered by AbleSci AI